| Financial Year |
March 31 2023 |
| Monetary Funds |
148,099,356.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
280,114,145.03 |
| Advances to Suppliers |
23,984,755.76 |
| Other Receivables |
10,717,981.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
51,514,645.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
74,765,380.22 |
| Total Current Assets |
590,185,192.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
22,730,195.30 |
| Investment Properties |
28,670,169.50 |
| Fixed Assetes |
242,638,480.26 |
| Under-construction Projects |
141,509.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,680,224.59 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,153,642.16 |
| Deferred Income Tax Assets |
36,467,232.19 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
361,510,209.39 |
| Total Assets |
951,695,402.32 |
| Short-Term Loans |
80,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,776,291.60 |
| Accounts Payable |
148,795,227.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
248,598.74 |
| Taxes Payable |
911,195.62 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,148,771.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
402,201.85 |
| Other Current Liabilities |
2,322,095.89 |
| Sub-Total of Current Liabilities |
265,088,067.71 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
866,779.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,861,114.84 |
| Total Liabilities |
280,949,182.55 |
| Paid-In Capital(Or Share Stock) |
253,884,600.00 |
| Capital Surplus |
234,993,508.35 |
| Surplus Reserve |
31,744,577.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
138,837,432.77 |
| Minority Stockholder's Interest |
11,286,101.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
659,460,118.31 |
| Owner's Equity（Stockholder's Equity） |
670,746,219.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
951,695,402.32 |
